APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metastatic Prostate

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Metastatic Prostate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025199 pages

Choose your research edition.

Industry ResearchMetastatic Prostate Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Metastatic Prostate Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Metastatic Prostate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metastatic Prostate Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Metastatic Prostate Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Metastatic Prostate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Metastatic Prostate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metastatic Prostate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metastatic Prostate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Metastatic Prostate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metastatic Prostate include Genentech, BeiGene, Amgen, Zenith Epigenetics Ltd., VasGene Therapeutics, Inc., Telix Pharmaceuticals, SeleXel, Myovant Biosciences and Immunomedics(Gilead Sciences, Inc.), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Metastatic Prostate market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metastatic Prostate and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metastatic Prostate revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Metastatic Prostate market size, projected growth trends, production technologies, key applications, and end-use industries.

Metastatic Prostate Segment by Company

Genentech

BeiGene

Amgen

Zenith Epigenetics Ltd.

VasGene Therapeutics, Inc.

Telix Pharmaceuticals

SeleXel

Myovant Biosciences

Immunomedics(Gilead Sciences, Inc.)

eFFECTOR Therapeutics

Arvinas Inc.

AB Science

Metastatic Prostate Segment by Type

Mono

Mono/Combination

Combination

Metastatic Prostate Segment by Application

Hospital

Drug Store

Online Pharmacy

Metastatic Prostate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metastatic Prostate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metastatic Prostate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metastatic Prostate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Metastatic Prostate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Metastatic Prostate industry.

Chapter 3: Detailed analysis of Metastatic Prostate companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metastatic Prostaterevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Metastatic Prostate Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Mono Table 3. Key Players of Mono/Combination Table 4. Key Players of Combination Table 4. Global Metastatic Prostate Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Drug Store Table 7. Key Players of Online Pharmacy Table 8. Global Metastatic Prostate Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Metastatic Prostate Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Metastatic Prostate Market Share by Region (2021-2026) Table 11. Global Metastatic Prostate Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Metastatic Prostate Market Share by Region (2027-2032) Table 13. Metastatic Prostate Industry Trends Table 14. Metastatic Prostate Industry Drivers Table 15. Metastatic Prostate Industry Opportunities and Challenges Table 16. Metastatic Prostate Industry Restraints Table 17. Global Metastatic Prostate Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Metastatic Prostate Revenue Market Share by Company (2021-2026) Table 19. Global Metastatic Prostate Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Metastatic Prostate Key Company Head Office and Area Served Table 21. Global Metastatic Prostate Company, Product Type & Application Table 22. Global Metastatic Prostate Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Metastatic Prostate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Metastatic Prostate Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Metastatic Prostate Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Metastatic Prostate Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Metastatic Prostate Revenue Market Share by Type (2021-2026) Table 29. Global Metastatic Prostate Revenue Market Share by Type (2027-2032) Table 30. Global Metastatic Prostate Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Metastatic Prostate Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Metastatic Prostate Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Metastatic Prostate Revenue Market Share by Application (2021-2026) Table 34. Global Metastatic Prostate Revenue Market Share by Application (2027-2032) Table 35. Genentech Company Information Table 36. Genentech Business Overview Table 37. Genentech Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Genentech Metastatic Prostate Product Portfolio Table 39. Genentech Recent Development Table 40. BeiGene Company Information Table 41. BeiGene Business Overview Table 42. BeiGene Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. BeiGene Metastatic Prostate Product Portfolio Table 44. BeiGene Recent Development Table 45. Amgen Company Information Table 46. Amgen Business Overview Table 47. Amgen Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Amgen Metastatic Prostate Product Portfolio Table 49. Amgen Recent Development Table 50. Zenith Epigenetics Ltd. Company Information Table 51. Zenith Epigenetics Ltd. Business Overview Table 52. Zenith Epigenetics Ltd. Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Zenith Epigenetics Ltd. Metastatic Prostate Product Portfolio Table 54. Zenith Epigenetics Ltd. Recent Development Table 55. VasGene Therapeutics, Inc. Company Information Table 56. VasGene Therapeutics, Inc. Business Overview Table 57. VasGene Therapeutics, Inc. Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. VasGene Therapeutics, Inc. Metastatic Prostate Product Portfolio Table 59. VasGene Therapeutics, Inc. Recent Development Table 60. Telix Pharmaceuticals Company Information Table 61. Telix Pharmaceuticals Business Overview Table 62. Telix Pharmaceuticals Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Telix Pharmaceuticals Metastatic Prostate Product Portfolio Table 64. Telix Pharmaceuticals Recent Development Table 65. SeleXel Company Information Table 66. SeleXel Business Overview Table 67. SeleXel Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. SeleXel Metastatic Prostate Product Portfolio Table 69. SeleXel Recent Development Table 70. Myovant Biosciences Company Information Table 71. Myovant Biosciences Business Overview Table 72. Myovant Biosciences Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Myovant Biosciences Metastatic Prostate Product Portfolio Table 74. Myovant Biosciences Recent Development Table 75. Immunomedics(Gilead Sciences, Inc.) Company Information Table 76. Immunomedics(Gilead Sciences, Inc.) Business Overview Table 77. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Product Portfolio Table 79. Immunomedics(Gilead Sciences, Inc.) Recent Development Table 80. eFFECTOR Therapeutics Company Information Table 81. eFFECTOR Therapeutics Business Overview Table 82. eFFECTOR Therapeutics Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. eFFECTOR Therapeutics Metastatic Prostate Product Portfolio Table 84. eFFECTOR Therapeutics Recent Development Table 85. Arvinas Inc. Company Information Table 86. Arvinas Inc. Business Overview Table 87. Arvinas Inc. Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Arvinas Inc. Metastatic Prostate Product Portfolio Table 89. Arvinas Inc. Recent Development Table 90. AB Science Company Information Table 91. AB Science Business Overview Table 92. AB Science Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. AB Science Metastatic Prostate Product Portfolio Table 94. AB Science Recent Development Table 95. North America Metastatic Prostate Market Size by Type (2021-2026) & (US$ Million) Table 96. North America Metastatic Prostate Market Size by Type (2027-2032) & (US$ Million) Table 97. North America Metastatic Prostate Market Size by Application (2021-2026) & (US$ Million) Table 98. North America Metastatic Prostate Market Size by Application (2027-2032) & (US$ Million) Table 99. North America Metastatic Prostate Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Metastatic Prostate Market Size by Country (2021-2026) Table 101. North America Metastatic Prostate Market Size by Country (2027-2032) Table 102. Europe Metastatic Prostate Market Size by Type (2021-2026) & (US$ Million) Table 103. Europe Metastatic Prostate Market Size by Type (2027-2032) & (US$ Million) Table 104. Europe Metastatic Prostate Market Size by Application (2021-2026) & (US$ Million) Table 105. Europe Metastatic Prostate Market Size by Application (2027-2032) & (US$ Million) Table 106. Europe Metastatic Prostate Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Metastatic Prostate Market Size by Country (2021-2026) Table 108. Europe Metastatic Prostate Market Size by Country (2027-2032) Table 109. China Metastatic Prostate Market Size by Type (2021-2026) & (US$ Million) Table 110. China Metastatic Prostate Market Size by Type (2027-2032) & (US$ Million) Table 111. China Metastatic Prostate Market Size by Application (2021-2026) & (US$ Million) Table 112. China Metastatic Prostate Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Metastatic Prostate Market Size by Type (2021-2026) & (US$ Million) Table 114. Asia Metastatic Prostate Market Size by Type (2027-2032) & (US$ Million) Table 115. Asia Metastatic Prostate Market Size by Application (2021-2026) & (US$ Million) Table 116. Asia Metastatic Prostate Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Metastatic Prostate Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Metastatic Prostate Market Size by Country (2021-2026) Table 119. Asia Metastatic Prostate Market Size by Country (2027-2032) Table 120. South America, Middle East & Africa Metastatic Prostate Market Size by Type (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Metastatic Prostate Market Size by Type (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Metastatic Prostate Market Size by Application (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Metastatic Prostate Market Size by Application (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Metastatic Prostate Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. South America, Middle East & Africa Metastatic Prostate Market Size by Country (2021-2026) Table 126. South America, Middle East & Africa Metastatic Prostate Market Size by Country (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Metastatic Prostate Product Image Figure 2. Global Metastatic Prostate Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Metastatic Prostate Market Share by Type: 2025 VS 2032 Figure 4. Mono Image Figure 5. Mono/Combination Image Figure 6. Combination Image Figure 7. Global Metastatic Prostate Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Metastatic Prostate Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Drug Store Image Figure 11. Online Pharmacy Image Figure 12. Global Metastatic Prostate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 14. Global Metastatic Prostate Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Metastatic Prostate Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Metastatic Prostate Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Metastatic Prostate Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Metastatic Prostate Revenue Market Share by Type (2021-2032) Figure 21. Global Metastatic Prostate Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Metastatic Prostate Revenue Market Share by Application (2021-2032) Figure 23. North America Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 24. North America Metastatic Prostate Market Share by Type (2021-2032) Figure 25. North America Metastatic Prostate Market Share by Application (2021-2032) Figure 26. North America Metastatic Prostate Market Share by Country (2021-2032) Figure 27. United States Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 28. Canada Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 30. Europe Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 31. Europe Metastatic Prostate Market Share by Type (2021-2032) Figure 32. Europe Metastatic Prostate Market Share by Application (2021-2032) Figure 33. Europe Metastatic Prostate Market Share by Country (2021-2032) Figure 34. Germany Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 35. France Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 37. Italy Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 38. Russia Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 40. China Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 41. China Metastatic Prostate Market Share by Type (2021-2032) Figure 42. China Metastatic Prostate Market Share by Application (2021-2032) Figure 43. Asia Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 44. Asia Metastatic Prostate Market Share by Type (2021-2032) Figure 45. Asia Metastatic Prostate Market Share by Application (2021-2032) Figure 46. Asia Metastatic Prostate Market Share by Country (2021-2032) Figure 47. Japan Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 51. India Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 52. Australia Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Metastatic Prostate Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Metastatic Prostate Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Metastatic Prostate Market Share by Country (2021-2032) Figure 57. Brazil Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 62. UAE Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 64. Chile Metastatic Prostate Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Mono
  • Mono/Combination
  • Combination
Applications
  • Hospital
  • Drug Store
  • Online Pharmacy
Companies covered
  • Genentech
  • BeiGene
  • Amgen
  • Zenith Epigenetics Ltd.
  • VasGene Therapeutics, Inc.
  • Telix Pharmaceuticals
  • SeleXel
  • Myovant Biosciences
  • Immunomedics(Gilead Sciences, Inc.)
  • eFFECTOR Therapeutics
  • Arvinas Inc.
  • AB Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Metastatic Prostate Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Mono
  5. 1.2.3 Mono/Combination
  6. 1.2.4 Combination
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Metastatic Prostate Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Drug Store
  11. 1.3.4 Online Pharmacy
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Metastatic Prostate Growth Trends by Region
  14. 1.5.1 Global Metastatic Prostate Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Metastatic Prostate Market Size by Region (2021-2026)
  16. 1.5.3 Metastatic Prostate Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Metastatic Prostate Market Dynamics
  1. 2.1 Metastatic Prostate Industry Trends
  2. 2.2 Metastatic Prostate Industry Drivers
  3. 2.3 Metastatic Prostate Industry Opportunities and Challenges
  4. 2.4 Metastatic Prostate Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Metastatic Prostate Revenue by Company (2021-2026)
  2. 3.2 Global Metastatic Prostate Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Metastatic Prostate Key Company Head office and Area Served
  4. 3.4 Global Metastatic Prostate Company, Product Type & Application
  5. 3.5 Global Metastatic Prostate Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Metastatic Prostate Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Metastatic Prostate Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Metastatic Prostate Tier 1, Tier 2, and Tier 3
4 Metastatic Prostate Market by Type
  1. 4.1 Global Metastatic Prostate Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Metastatic Prostate Market Size by Type (2021-2032)
  3. 4.3 Global Metastatic Prostate Market Size Share by Type (2021-2032)
5 Metastatic Prostate Market by Application
  1. 5.1 Global Metastatic Prostate Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Metastatic Prostate Market Size by Application (2021-2032)
  3. 5.3 Global Metastatic Prostate Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Genentech
  2. 6.1.1 Genentech Company Information
  3. 6.1.2 Genentech Business Overview
  4. 6.1.3 Genentech Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Genentech Metastatic Prostate Product Portfolio
  6. 6.1.5 Genentech Recent Developments
  7. 6.2 BeiGene
  8. 6.2.1 BeiGene Company Information
  9. 6.2.2 BeiGene Business Overview
  10. 6.2.3 BeiGene Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 BeiGene Metastatic Prostate Product Portfolio
  12. 6.2.5 BeiGene Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Amgen Metastatic Prostate Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Zenith Epigenetics Ltd.
  20. 6.4.1 Zenith Epigenetics Ltd. Company Information
  21. 6.4.2 Zenith Epigenetics Ltd. Business Overview
  22. 6.4.3 Zenith Epigenetics Ltd. Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Zenith Epigenetics Ltd. Metastatic Prostate Product Portfolio
  24. 6.4.5 Zenith Epigenetics Ltd. Recent Developments
  25. 6.5 VasGene Therapeutics, Inc.
  26. 6.5.1 VasGene Therapeutics, Inc. Company Information
  27. 6.5.2 VasGene Therapeutics, Inc. Business Overview
  28. 6.5.3 VasGene Therapeutics, Inc. Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 VasGene Therapeutics, Inc. Metastatic Prostate Product Portfolio
  30. 6.5.5 VasGene Therapeutics, Inc. Recent Developments
  31. 6.6 Telix Pharmaceuticals
  32. 6.6.1 Telix Pharmaceuticals Company Information
  33. 6.6.2 Telix Pharmaceuticals Business Overview
  34. 6.6.3 Telix Pharmaceuticals Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Telix Pharmaceuticals Metastatic Prostate Product Portfolio
  36. 6.6.5 Telix Pharmaceuticals Recent Developments
  37. 6.7 SeleXel
  38. 6.7.1 SeleXel Company Information
  39. 6.7.2 SeleXel Business Overview
  40. 6.7.3 SeleXel Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 SeleXel Metastatic Prostate Product Portfolio
  42. 6.7.5 SeleXel Recent Developments
  43. 6.8 Myovant Biosciences
  44. 6.8.1 Myovant Biosciences Company Information
  45. 6.8.2 Myovant Biosciences Business Overview
  46. 6.8.3 Myovant Biosciences Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Myovant Biosciences Metastatic Prostate Product Portfolio
  48. 6.8.5 Myovant Biosciences Recent Developments
  49. 6.9 Immunomedics(Gilead Sciences, Inc.)
  50. 6.9.1 Immunomedics(Gilead Sciences, Inc.) Company Information
  51. 6.9.2 Immunomedics(Gilead Sciences, Inc.) Business Overview
  52. 6.9.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Product Portfolio
  54. 6.9.5 Immunomedics(Gilead Sciences, Inc.) Recent Developments
  55. 6.10 eFFECTOR Therapeutics
  56. 6.10.1 eFFECTOR Therapeutics Company Information
  57. 6.10.2 eFFECTOR Therapeutics Business Overview
  58. 6.10.3 eFFECTOR Therapeutics Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 eFFECTOR Therapeutics Metastatic Prostate Product Portfolio
  60. 6.10.5 eFFECTOR Therapeutics Recent Developments
  61. 6.11 Arvinas Inc.
  62. 6.11.1 Arvinas Inc. Company Information
  63. 6.11.2 Arvinas Inc. Business Overview
  64. 6.11.3 Arvinas Inc. Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Arvinas Inc. Metastatic Prostate Product Portfolio
  66. 6.11.5 Arvinas Inc. Recent Developments
  67. 6.12 AB Science
  68. 6.12.1 AB Science Company Information
  69. 6.12.2 AB Science Business Overview
  70. 6.12.3 AB Science Metastatic Prostate Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 AB Science Metastatic Prostate Product Portfolio
  72. 6.12.5 AB Science Recent Developments
7 North America
  1. 7.1 North America Metastatic Prostate Market Size (2021-2032)
  2. 7.2 North America Metastatic Prostate Market Size by Type
  3. 7.2.1 North America Metastatic Prostate Market Size by Type (2021-2026)
  4. 7.2.2 North America Metastatic Prostate Market Size by Type (2027-2032)
  5. 7.2.3 North America Metastatic Prostate Market Share by Type (2021-2032)
  6. 7.3 North America Metastatic Prostate Market Size by Application
  7. 7.3.1 North America Metastatic Prostate Market Size by Application (2021-2026)
  8. 7.3.2 North America Metastatic Prostate Market Size by Application (2027-2032)
  9. 7.3.3 North America Metastatic Prostate Market Share by Application (2021-2032)
  10. 7.4 North America Metastatic Prostate Market Size by Country
  11. 7.4.1 North America Metastatic Prostate Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Metastatic Prostate Market Size by Country (2021-2026)
  13. 7.4.3 North America Metastatic Prostate Market Size by Country (2027-2032)
  14. 7.4.4 North America Metastatic Prostate Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Metastatic Prostate Market Size (2021-2032)
  2. 8.2 Europe Metastatic Prostate Market Size by Type
  3. 8.2.1 Europe Metastatic Prostate Market Size by Type (2021-2026)
  4. 8.2.2 Europe Metastatic Prostate Market Size by Type (2027-2032)
  5. 8.2.3 Europe Metastatic Prostate Market Share by Type (2021-2032)
  6. 8.3 Europe Metastatic Prostate Market Size by Application
  7. 8.3.1 Europe Metastatic Prostate Market Size by Application (2021-2026)
  8. 8.3.2 Europe Metastatic Prostate Market Size by Application (2027-2032)
  9. 8.3.3 Europe Metastatic Prostate Market Share by Application (2021-2032)
  10. 8.4 Europe Metastatic Prostate Market Size by Country
  11. 8.4.1 Europe Metastatic Prostate Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Metastatic Prostate Market Size by Country (2021-2026)
  13. 8.4.3 Europe Metastatic Prostate Market Size by Country (2027-2032)
  14. 8.4.4 Europe Metastatic Prostate Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Metastatic Prostate Market Size (2021-2032)
  2. 9.2 China Metastatic Prostate Market Size by Type
  3. 9.2.1 China Metastatic Prostate Market Size by Type (2021-2026)
  4. 9.2.2 China Metastatic Prostate Market Size by Type (2027-2032)
  5. 9.2.3 China Metastatic Prostate Market Share by Type (2021-2032)
  6. 9.3 China Metastatic Prostate Market Size by Application
  7. 9.3.1 China Metastatic Prostate Market Size by Application (2021-2026)
  8. 9.3.2 China Metastatic Prostate Market Size by Application (2027-2032)
  9. 9.3.3 China Metastatic Prostate Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Metastatic Prostate Market Size (2021-2032)
  2. 10.2 Asia Metastatic Prostate Market Size by Type
  3. 10.2.1 Asia Metastatic Prostate Market Size by Type (2021-2026)
  4. 10.2.2 Asia Metastatic Prostate Market Size by Type (2027-2032)
  5. 10.2.3 Asia Metastatic Prostate Market Share by Type (2021-2032)
  6. 10.3 Asia Metastatic Prostate Market Size by Application
  7. 10.3.1 Asia Metastatic Prostate Market Size by Application (2021-2026)
  8. 10.3.2 Asia Metastatic Prostate Market Size by Application (2027-2032)
  9. 10.3.3 Asia Metastatic Prostate Market Share by Application (2021-2032)
  10. 10.4 Asia Metastatic Prostate Market Size by Country
  11. 10.4.1 Asia Metastatic Prostate Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Metastatic Prostate Market Size by Country (2021-2026)
  13. 10.4.3 Asia Metastatic Prostate Market Size by Country (2027-2032)
  14. 10.4.4 Asia Metastatic Prostate Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Metastatic Prostate Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Metastatic Prostate Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Metastatic Prostate Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Metastatic Prostate Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Metastatic Prostate Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Metastatic Prostate Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Metastatic Prostate Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Metastatic Prostate Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Metastatic Prostate Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Metastatic Prostate Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Metastatic Prostate Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Metastatic Prostate Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Metastatic Prostate Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Metastatic Prostate Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst